KV
Krishnakumar Vaidyanathan
About Krishnakumar Vaidyanathan
Data last updated:
Krishnakumar Vaidyanathan is a Whole-Time Director at Eris Lifesciences Limited (since 2020), Director at Eris Oaknet Healthcare Private Limited (since 2022) and Director at Swiss Parenterals Limited (since 2024), and holds 2 more current directorships. The companies operate in Pharma, Life Sciences and Travel and Hospitality. The 4 current companies with reported revenue have a combined latest revenue of ₹5,624 Cr; the largest is Eris Lifesciences Limited at ₹5,069 Cr (FY 2025). Earlier, Krishnakumar Vaidyanathan was a Partner at Ernst & Young Llp (2013–2021).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Whole-Time Director | 20 Dec 2020 | 2007 | ₹5,069 Cr (FY 2025) | Active | |
| Director | 12 May 2022 | 2011 | ₹253 Cr (FY 2023) | Active | |
| Director | 15 Feb 2024 | 1997 | ₹232 Cr (FY 2023) | Active | |
| Director | 17 Dec 2021 | 2002 | ₹71.10 Cr (FY 2025) | Active | |
| Director | 28 Feb 2025 | 2021 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Partner | 01 Apr 2013 | 2013 | ₹11,012 Cr (FY 2023) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Krishnakumar Vaidyanathan
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Krishnakumar Vaidyanathan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Krishnakumar Vaidyanathan
Krishnakumar Vaidyanathan currently holds 5 directorships: Eris Lifesciences Limited (Whole-Time Director, since 20 Dec 2020, revenue ₹5,069 Cr (FY 2025)); Eris Oaknet Healthcare Private Limited (Director, since 12 May 2022, revenue ₹253 Cr (FY 2023)); Swiss Parenterals Limited (Director, since 15 Feb 2024, revenue ₹232 Cr (FY 2023)); Eris M. J. Biopharm Private Limited (Director, since 17 Dec 2021, revenue ₹71.10 Cr (FY 2025)); Levim Lifetech Private Limited (Director, since 28 Feb 2025).
Krishnakumar Vaidyanathan was first appointed on 01 Apr 2013 as Partner at Ernst & Young Llp. The most recent appointment on record is 28 Feb 2025 at Levim Lifetech Private Limited.
The 4 current companies of Krishnakumar Vaidyanathan that report revenue have a combined latest revenue of ₹5,624 Cr: Eris Lifesciences Limited ₹5,069 Cr (FY 2025); Eris Oaknet Healthcare Private Limited ₹253 Cr (FY 2023); Swiss Parenterals Limited ₹232 Cr (FY 2023); Eris M. J. Biopharm Private Limited ₹71.10 Cr (FY 2025).
Krishnakumar Vaidyanathan held 1 earlier board appointment: Ernst & Young Llp (Partner, 01 Apr 2013 to 05 Jan 2021).
The current boards of Krishnakumar Vaidyanathan's companies include Amit Indubhushan Bakshi (Eris Lifesciences Limited), Inderjeet Singh Negi (Eris Lifesciences Limited), Kalpana Vasantrai Unadkat (Eris Lifesciences Limited), Kaushal Kamlesh Shah (Eris Lifesciences Limited), Milind Talegaonkar (Eris Lifesciences Limited), Prashant Gupta (Eris Lifesciences Limited), among others.